Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease
Jamol UzokovCardiology, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, UzbekistanB. AlyaviCardiology, Tashkent Pediatric Medical Institute, Tashkent, UzbekistanA. Kh. AbdullaevCardiology, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, UzbekistanD. OrzievCardiology, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, UzbekistanI. MadjitovCardiology, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 0